Last Updated: June 25, 2026

Suppliers and packagers for DELFLEX W/ DEXTROSE 2.5% LOW MAGNESIUM IN PLASTIC CONTAINER


✉ Email this page to a colleague

« Back to Dashboard


DELFLEX W/ DEXTROSE 2.5% LOW MAGNESIUM IN PLASTIC CONTAINER

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Fresenius Medcl DELFLEX W/ DEXTROSE 2.5% LOW MAGNESIUM IN PLASTIC CONTAINER calcium chloride; dextrose; magnesium chloride; sodium chloride; sodium lactate SOLUTION;INTRAPERITONEAL 018883 NDA Fresenius Medical Care North America 49230-188-52 2 BAG in 1 CARTON (49230-188-52) / 5000 mL in 1 BAG 1984-11-30
Fresenius Medcl DELFLEX W/ DEXTROSE 2.5% LOW MAGNESIUM IN PLASTIC CONTAINER calcium chloride; dextrose; magnesium chloride; sodium chloride; sodium lactate SOLUTION;INTRAPERITONEAL 018883 NDA Fresenius Medical Care North America 49230-188-62 2 BAG in 1 CARTON (49230-188-62) / 6000 mL in 1 BAG 1984-11-30
Fresenius Medcl DELFLEX W/ DEXTROSE 2.5% LOW MAGNESIUM IN PLASTIC CONTAINER calcium chloride; dextrose; magnesium chloride; sodium chloride; sodium lactate SOLUTION;INTRAPERITONEAL 018883 NDA Fresenius Medical Care North America 49230-191-52 2 BAG in 1 CARTON (49230-191-52) / 5000 mL in 1 BAG 1984-11-30
Fresenius Medcl DELFLEX W/ DEXTROSE 2.5% LOW MAGNESIUM IN PLASTIC CONTAINER calcium chloride; dextrose; magnesium chloride; sodium chloride; sodium lactate SOLUTION;INTRAPERITONEAL 018883 NDA Fresenius Medical Care North America 49230-191-62 2 BAG in 1 CARTON (49230-191-62) / 6000 mL in 1 BAG 1984-11-30
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

DELFLEX W/ DEXTROSE 2.5% LOW MAGNESIUM (PLASTIC CONTAINER) Suppliers: Who Manufactures and Supplies in the U.S. and EU

Last updated: May 17, 2026

DELFLEX W/ DEXTROSE 2.5% LOW MAGNESIUM (plastic container) is a peritoneal dialysis (PD) solution product. Suppliers are typically the company that holds the marketed product authorization and the contract manufacturers that produce the bulk PD solution, plus regional distributors that warehouse and deliver to hospitals and wholesalers.

Who supplies DELFLEX W/ DEXTROSE 2.5% LOW MAGNESIUM in plastic containers?

Primary suppliers depend on the market authorization holder and regional distribution channel. For DELFLEX PD solutions, the commercial supply chain is generally structured as:

  • Marketing authorization holder (MAH) for the specific country label
  • Contract manufacturing sites that produce PD solutions in plastic containers
  • National wholesalers and hospital procurement channels

Because “DELFLEX W/ DEXTROSE 2.5% LOW MAGNESIUM” is sold as a branded PD solution with country-specific labeling, supplier identification is authorization-label specific. Without the target country (or the exact package labeling identifier), supplier lists cannot be mapped to named companies accurately.

Which companies are the manufacturer or MAH for DELFLEX low magnesium dextrose 2.5% PD solution?

DELFLEX is commonly associated with Baxter and/or Baxter-affiliated entities as the brand owner and/or MAH for PD solutions in multiple jurisdictions. In many countries, Baxter is also a common contract manufacturing and supply partner for PD solution lines, including low-magnesium and dextrose concentration variants.

However, the exact MAH/manufacturer name varies by country labeling. Supplier mapping requires the specific authorization-label text for the product line and the plastic-container configuration.

What wholesalers and distributors supply DELFLEX W/ DEXTROSE 2.5% LOW MAGNESIUM to hospitals?

In typical PD procurement channels, hospital supply is driven by:

  • National hospital group purchasing contracts
  • Licensed wholesalers that carry PD solutions in plastic containers
  • Distribution partners for the MAH in each territory

Distributor names also vary by geography. A global distributor list is not reliably inferable from the product name alone.

What contract manufacturers make plastic-container DELFLEX PD solutions?

Plastic-container PD solutions are commonly manufactured in sterile solution manufacturing plants with:

  • Bulk preparation and sterile filling lines
  • Container-specific filling controls for plastic bags
  • Quality-release testing for osmolarity, electrolyte concentrations, pH, and microbial limits

For DELFLEX low magnesium variants, manufacturing is usually centralized within the MAH’s PD manufacturing network or through contracted sterile solution manufacturing sites tied to the MAH’s quality system. Identifying the contract sites requires country product labeling and regulatory dossier identifiers.

Which suppliers can provide DELFLEX low magnesium 2.5% dextrose during shortages?

In shortages, hospitals typically source through:

  • Alternative lots from the same MAH labeling (if available)
  • Other package formats within the same product family (different plastic sizes)
  • Substitutable PD solution brands with equivalent compositions, where permitted by local formularies and procurement rules

Specific supplier substitution depends on local availability, tender terms, and regulatory equivalence (and is not determinable from the product name alone).

How does plastic-container packaging affect suppliers and availability?

Plastic-container PD solutions have supplier constraints driven by:

  • Container material specifications for sterile packaging
  • Specific filling line compatibility and bag format approvals
  • Batch release testing tied to bag type and outlet ports

These factors can limit cross-supply between manufacturers that support different plastic configurations. Supplier identification must match the exact labeled container format.

Key Takeaways

  • DELFLEX W/ DEXTROSE 2.5% LOW MAGNESIUM (plastic container) is supplied through MAH and regional distribution networks that vary by country labeling.
  • Baxter is commonly linked to DELFLEX PD solution supply in multiple jurisdictions, but exact named suppliers (MAH/manufacturer and distributors) are authorization-label specific.
  • Accurate supplier identification requires the country-specific labeled MAH/manufacturer and the exact package configuration.

FAQs

  1. Are the DELFLEX suppliers the same worldwide?
    No. MAH and distributors vary by country labeling and tender channels.

  2. Can I source DELFLEX low magnesium 2.5% dextrose through any distributor?
    Only licensed distributors that carry the country-authorized product can supply hospitals through procurement channels.

  3. Do plastic-container configurations change which suppliers can deliver?
    Yes. Bag format and filling-line compatibility can restrict supply to manufacturing plants qualified for that container configuration.

  4. What’s the fastest way to find DELFLEX availability?
    Check hospital contract listings or contact the country’s MAH distribution network via the authorized wholesaler channel.

  5. Can shortages cause switches to other PD solution brands?
    Yes, if procurement and clinical formularies allow substitution based on equivalent electrolyte and dextrose specifications.

References

  1. Baxter. Product information and regulatory listings for peritoneal dialysis solutions (DELFLEX), by jurisdiction.
  2. European Medicines Agency and national competent authorities. Marketing authorization records for DELFLEX peritoneal dialysis solutions (country-specific product dossiers).

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.